<html><style> .textDiv { width: 900px; border: 25px solid #58D3F7; padding: 25px; margin: 25px; font-family: 'Arial', Times, serif; font-size: 16px; text-align: justify;} .title { margin: 50px 50px 50px 25px; font-family: 'Arial', Times, serif; font-size: 40px; font-weight: bold; color:  #58D3F7; text-align: left;} </style><head></head><body><div class='title'>extractUncertainty_Unspecified</div><div class='textDiv'>U.S. IPO Weekly Recap: 2 IPOs Price, But MaxPoint Misses The Point | Seeking Alpha Mar.<span style='background-color: #A9E2F3'>7, 2015 12:41 PM ET �|� Includes: ETSY , MXPT , SMMT , SUM by: Renaissance Capital IPO Research IPO highlights during the week of March 2, 2015: 2 IPOs priced in the past week, an adtech and a biotech 2015 IPO returns reached their highest levels, averaging +17% IPO activity remains slow for a soaring stock market Etsy filed: could be largest New York tech IPO in 15 years Before today, only one $50 million+ tech IPO in the past year fell more than 5% on its first day - Candy Crush maker King Digital (NYSE: KING ).</span><span style='background-color: #A9E2F3'>MaxPoint Interactive's 15% first-day fall is especially unusual given the track record of lead underwriter Goldman Sachs.</span>Since 2009, Goldman has been the lead left on 117 IPOs, and only one Ruckus Wireless (NYSE: RKUS ) had a worse first day, making MaxPoint a poor follow-up to its last tech deal, Inovalon (NASDAQ: INOV ), which debuted with a 0% return.As mentioned in the Week Ahead , several adtech IPOs in the past two years (Tremor Video (NYSE: TRMR ), Rocket Fuel (NASDAQ: FUEL ), Marin Software (NYSE: MRIN ), YuMe (NYSE: YUME )) have blown up - an unwelcome red flag ahead of MaxPoint.<span style='background-color: #A9E2F3'>The company may have been wise to follow top-performing peer TubeMogul ( TUBE ; +82%), which slashed its offer price by 42% last year to get done.</span>If US investors have gone gaga for biotechs, UK-based Summit Therapeutics joined the NASDAQ at the right time.The company, which was already listed in London, is developing therapies for the rare disease Duchenne Muscular Dystrophy, as well as an infection associated with antibiotics.Summit traded at $11.50 last week, but its stock price had fallen to $9.90 by Wednesday; the biotech raised $34 million and traded up slightly.<span style='background-color: #A9E2F3'>It had the good fortune of seeing close peer Prosensa (NASDAQ: RNA ) acquired for $860 million last November and PTC Therapeutics (NASDAQ: PTCT ) spike 35% in February amid rumors of an acquisition.</span>Second Summit: One IPO on next week's IPO calendar Just one IPO is scheduled for next week.<span style='background-color: #A9E2F3'>Formed by Blackstone (NYSE: BX ) in 2009, Summit Materials (Pending: SUM ) is looking to raise $400 million.</span>Summit, which had $1.2 billion in sales during 2014, provides concrete and aggregates for construction.<span style='background-color: #A9E2F3'>As we'll discuss in our next blog, hipster online marketplace Etsy (Pending: ETSY ) filed for an IPO rumored to raise $300 million or more.</span>That's a lot of skinny jeans and v-necks (locally-sourced and handmade using recycled cloth).<span style='background-color: #A9E2F3'>The Renaissance IPO Index, a market cap weighted basket of newly public companies that is designed to represent the US IPO market, has traded up nearly 6% year-to-date, close to its all-time high.</span>The IPO market remains open to new issuance, if deals are priced right.Renaissance Capital's IPO ETF (NYSEARCA: IPO ) tracks the index, and top ETF holdings include Twitter (NYSE: TWTR ), Zoetis (NYSE: ZTS ), Alibaba (NYSE: BABA ), Hilton (NYSE: HLT ) and Ally Financial (NYSE: ALLY ).Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap.<span style='background-color: #A9E2F3'>Please be aware of the risks associated with these stocks.</span>We only use your contact details to reply to your request for more information.We do not sell the personal contact data you submit to anyone else.Thank you for your interest in Seeking Alpha PRO We look forward to contacting you shortly for a conversation.Our PRO subscription service was created for fund managers, and the cost of the product is prohibitive for most individual investors.PRO Alerts is our flagship product for individual investors who want to be faster and smarter about their stocks.To learn more about it, click here.If you are an investment professional with over $1M AUM and received this message in error, click here and you will be contacted shortly.We look forward to contacting you when we have an individual investor product ready!</div></body></html>